V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196092 | 20152411 | 1.67 | 107.2 | Palliative (P) | 2020-04-25 | 2020-08-04 | Docetaxel | 02 | N | DOCETAXEL | 101168770 |
| 20196096 | 20152412 | 1.6 | 69.2 | Palliative (P) | 2019-10-10 | 2019-10-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101084562 |
| 20196100 | 20152413 | 1.74 | 60.2 | null | 2018-07-18 | 2018-07-27 | Docetaxel | 02 | null | DOCETAXEL | 100058455 |
| 20196104 | 20152414 | 1.61 | 72.4 | Palliative (P) | 2017-12-24 | 2017-12-24 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100821808 |
| 20196112 | 20152415 | 1.89 | 66.4 | Palliative (P) | 2021-05-06 | 2021-06-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100898841 |
| 20196114 | 20152416 | 1.59 | 69.9 | Adjuvant (A) | 2017-01-08 | 2017-01-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100943119 |
| 20196117 | 20152417 | 1.66 | 93 | Palliative (P) | null | 2016-04-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101588551 |
| 20196122 | 20152418 | null | 76.8 | Palliative (P) | 2017-11-20 | 2017-12-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101731193 |
| 20196123 | 20152419 | 1.62 | 43.4 | Palliative (P) | 2019-03-14 | 2019-03-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100610303 |
| 20196130 | 20152420 | 1.52 | 53.2 | Palliative (P) | 2019-09-16 | 2019-11-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100550422 |
| 20196133 | 20152421 | 1.91 | 60.8 | Palliative (P) | 2021-08-23 | 2021-10-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101390566 |
| 20196135 | 20152422 | 1.59 | 57.8 | null | null | 2018-11-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100122123 |
| 20196137 | 20152423 | 1.7 | 85.4 | null | 2019-09-01 | 2019-11-10 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101563005 |
| 20196140 | 20152424 | 1.54 | 62 | Palliative (P) | 2019-09-25 | 2019-10-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101403064 |
| 20196141 | 20152425 | 1.69 | 98.1 | Palliative (P) | 2022-01-30 | 2022-02-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100884311 |
| 20196142 | 20152426 | 1.79 | 87 | Adjuvant (A) | 2019-09-15 | 2020-04-07 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101100562 |
| 20196149 | 20152427 | 1.84 | 103 | null | 2019-02-07 | 2019-02-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100988001 |
| 20196155 | 20152428 | 1.7 | 64 | Palliative (P) | 2019-01-09 | 2019-03-11 | Docetaxel | 02 | N | DOCETAXEL | 101053525 |
| 20196159 | 20152429 | 1.67 | 61.1 | Adjuvant (A) | 2017-01-20 | 2017-01-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100323594 |
| 20196161 | 20152430 | 1.71 | 79.1 | Curative (C) | null | 2016-10-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100014688 |
| 20196164 | 20152431 | 1.61 | 82.5 | Palliative (P) | 2017-10-03 | 2017-10-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100613073 |
| 20196169 | 20152432 | 1.54 | 62.7 | Adjuvant (A) | null | 2020-07-14 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101726389 |
| 20196178 | 20152433 | 1.9 | 62.6 | Palliative (P) | 2019-07-30 | 2019-08-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100015199 |
| 20196179 | 20152434 | 1.71 | 80.2 | Palliative (P) | 2018-10-17 | 2019-07-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101658520 |
| 20196183 | 20152435 | 1.81 | 64.9 | null | 2018-04-30 | 2018-05-02 | Cetuximab + FOLFIRI cycle1 | 02 | null | CAPECITABINE + GEMCITABINE | 101663607 |
| 20196190 | 20152436 | 1.69 | 99 | null | 2014-07-19 | 2016-07-11 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100957844 |
| 20196191 | 20152437 | 1.79 | 77.6 | Palliative (P) | 2020-07-23 | 2020-08-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100126076 |
| 20196193 | 20152438 | 1.52 | 64.6 | Palliative (P) | 2018-04-16 | 2018-05-06 | Docetaxel | 02 | N | DOCETAXEL | 100301396 |
| 20196197 | 20152439 | 1.8 | 78 | Palliative (P) | 2020-05-19 | 2020-06-14 | Docetaxel | 02 | N | DOCETAXEL | 100991149 |
| 20196198 | 20152440 | 1.69 | 66.9 | Palliative (P) | 2019-04-29 | 2020-01-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100100818 |
| 20196200 | 20152441 | 1.83 | null | Palliative (P) | 2020-05-02 | 2020-05-05 | Docetaxel | 02 | N | DOCETAXEL | 100121292 |
| 20196201 | 20152442 | 1.62 | 82.1 | Palliative (P) | 2017-08-17 | 2017-08-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101636024 |
| 20196203 | 20152443 | 1.63 | 58.6 | null | 2018-12-28 | 2019-01-14 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101464327 |
| 20196206 | 20152444 | 1.86 | 73 | Adjuvant (A) | 2018-04-11 | 2021-03-31 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101635059 |
| 20196207 | 20152445 | 1.81 | 99.6 | Palliative (P) | 2018-08-31 | 2018-08-31 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101072396 |
| 20196216 | 20152446 | 1.68 | 69.8 | null | 2016-06-19 | 2016-10-15 | Gemcitabine + Capecitabine | 2 | null | CAPECITABINE + GEMCITABINE | 101829209 |
| 20196217 | 20152447 | 1.81 | 68.9 | null | null | 2018-12-04 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 101213082 |
| 20196220 | 20152448 | 1.65 | 93.4 | null | null | 2018-07-08 | Gemcitabine + Capecitabine | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101022604 |
| 20196224 | 20152449 | 1.74 | null | Neo-adjuvant (N) | 2019-05-30 | 2019-06-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100346927 |
| 20196228 | 20152450 | 1.84 | 70.2 | null | 2017-04-12 | 2017-04-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100241690 |
| 20196233 | 20152451 | 1.67 | 95.3 | Palliative (P) | 2019-07-22 | 2019-08-06 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100513282 |
| 20196255 | 20152453 | 1.74 | 55.4 | null | 2017-10-02 | 2017-10-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100508842 |
| 20196264 | 20152454 | 1.66 | null | Palliative (P) | 2016-09-10 | 2017-02-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100057688 |
| 20196266 | 20152455 | 1.85 | 77.4 | null | 2017-12-15 | 2017-12-21 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101131842 |
| 20196268 | 20152456 | 1.7 | 58.5 | Palliative (P) | 2017-10-24 | 2017-10-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100992481 |
| 20196270 | 20152457 | 1.63 | 67.3 | Neo-adjuvant (N) | 2017-03-16 | 2017-06-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101203033 |
| 20196271 | 20152458 | 1.68 | 77.4 | Palliative (P) | 2018-11-21 | 2019-01-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100317694 |
| 20196277 | 20152459 | 1.74 | 61.6 | Palliative (P) | 2017-12-31 | 2019-02-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100401513 |
| 20196283 | 20152460 | 1.88 | 73 | Palliative (P) | 2016-09-20 | 2017-08-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101430577 |
| 20196290 | 20152461 | 1.68 | 101 | null | 2019-02-14 | 2019-03-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101086706 |